Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2000
10/11/2000EP1042304A1 Triazine compounds for treatment of cns disorders
10/11/2000EP1042298A1 Polycyclic alpha-amino-epsilon-caprolactams and related compounds
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042288A1 Tripeptidyl peptidase inhibitors
10/11/2000EP1042275A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
10/11/2000EP1041992A1 Hyperhydrated citicoline, process and use
10/11/2000EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/11/2000EP1041988A1 A method of preventing abuse of opioid dosage forms
10/11/2000EP1041987A1 Opioid agonist/antagonist combinations
10/11/2000EP1041986A1 Pharmaceutically active compound and methods of use
10/11/2000EP1041984A1 Pharmaceutical composition for oral administration
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041880A1 A delivery of arginine to cause beneficial effects
10/11/2000EP0778768A4 Formulations and methods for providing prolonged local anesthesia
10/11/2000EP0710121B1 Method for treating multiple sclerosis
10/11/2000CN1269800A Tetrahydro Gamma-carbolines
10/11/2000CN1269799A Piperidinylmethyloxazolidinone derivative
10/11/2000CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments
10/11/2000CN1269362A 1,4-dichloropyridine-3,5-carboxylic-acid derivatives and preparation method thereof
10/11/2000CN1269359A Antimer pure acetacetates, its preparation method and use
10/11/2000CN1269358A Amino-butenate compound and preparation method thereof
10/11/2000CN1269357A Benzal compound and preparation method
10/11/2000CN1269211A Kehaiyin medicine
10/11/2000CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130228 Alzheimers
10/10/2000US6130222 Analgesics
10/10/2000US6130221 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
10/10/2000US6130215 Central nervous system
10/10/2000US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents
10/10/2000US6130058 Nucleotide sequences coding for n-methylaspartic acid receptor; for drug design and drug screening; antidepressants; anticonvulsants; antiepileptic agents; antiischemic agents; treatment of stroke, cerebral palsy
10/10/2000US6129925 Container filled with infusion liquids and infusion preparation
10/10/2000CA2106762C Bradykinin antagonist peptides
10/10/2000CA2067475C Carbostyril derivatives and their use
10/10/2000CA2028893C Morpholinols, their prepation and use
10/09/2000CA2310990A1 A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058359A1 Retro-inverso prosaposin-derived peptides and use thereof
10/05/2000WO2000058357A1 50 human secreted proteins
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058354A1 Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058311A1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
10/05/2000WO2000058310A1 Zolpidem salts
10/05/2000WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058301A1 N-[2-(4-aminophyl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-methanamine, production and therapeutic use thereof
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000058285A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
10/05/2000WO2000058282A2 Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments
10/05/2000WO2000058279A1 Diaryl derivatives and their use as medicaments
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057900A2 Factor for regulation of neurite growth
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057894A1 Use of valeriana for the treatment of restless leg syndrome and related disorders
10/05/2000WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000WO2000057865A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000WO2000057862A2 Use of gaba-b receptor ligands for the treatment of neurodegenerative diseases
10/05/2000WO2000057851A2 High potency dihydroergotamine compositions
10/05/2000WO2000057824A1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/05/2000WO2000057727A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions
10/05/2000WO2000032178A3 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments
10/05/2000WO2000032171A3 Autoahesive oral transmucosal delivery dosage form
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000031133A3 Potassium channel interactors and uses therefor
10/05/2000WO2000029574A3 Inflammation-associated genes
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000011167A3 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO1999053951A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369009A1 Factor for regulation of neurite growth
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368597A1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000CA2368587A1 High potency dihydroergotamine compositions
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368482A1 50 human secreted proteins
10/05/2000CA2368469A1 50 human secreted proteins
1 ... 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 ... 1833